Consortium of Multiple Sclerosis Centers Inc

Analysis

Consortium of Multiple Sclerosis Centers Inc is a registered charity in United States, based in Hackensack, NJ. It received its IRS tax-exemption ruling in October 1993, 33 years ago. Its declared purposes cover diseases, disorders and medical disciplines, which this site groups under health and saving lives. The IRS classifies it as a publicly supported organisation (gross receipts test) under section 501(c)(3), and contributions to it are listed as tax-deductible.

In the financial year ending December 2023, Consortium of Multiple Sclerosis Centers Inc reported income of $6.5m and spending of $6.6m, spending 102% of its income. Across the 5 years on record, from December 2019 to December 2023, income fell from $7.8m to $6.5m (-17%), an average of -4.7% a year. Over the whole period it spent 100% of the income it received.

Among 40,470 United States charities whose main cause is health and saving lives and that reported income, Consortium of Multiple Sclerosis Centers Inc sits at the 81st percentile: it is larger than about 81% of them. Against every charity in United States with reported income it ranks in the 93rd percentile, and in the 94th percentile within NJ. Charities of a similar size with the same main cause include Community Blood Holdings Inc ($6.5m), Nexleaf Analytics ($6.5m) and Hematology Oncology Pharmacy Association Inc ($6.5m).

On its Form 990 for the period ending December 2023, revenue came from contributions and grants 1.9% and program service revenue 95% of the total. Other salaries and wages came to $1.1m. At year end it held assets of $5.8m against liabilities of $2.9m, net assets of $2.9m. It reported 16 employees.